Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

血管拡張器を撤回する

J E Pohl, A C Burden

    Lancet (London, England)
    |May 10, 1980
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Cardiovascular screening for men at high risk in Heart of Birmingham Teaching Primary Care Trust: the 'Deadly Trio' programme.

    Journal of public health (Oxford, England)·2011
    Same author

    Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction.

    Diabetic medicine : a journal of the British Diabetic Association·2007
    Same author

    Psychological morbidity and problems of daily living in people with visual loss and diabetes: do they differ from people without diabetes?

    Diabetic medicine : a journal of the British Diabetic Association·2006
    Same author

    Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.

    British journal of cancer·2005
    Same author

    Mortality of South Asian patients with insulin-treated diabetes mellitus in the United Kingdom: a cohort study.

    Diabetic medicine : a journal of the British Diabetic Association·2004
    Same author

    Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.

    Diabetologia·2003
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

    Lancet (London, England)·2026
    関連記事をすべて見る